Followers | 9 |
Posts | 750 |
Boards Moderated | 0 |
Alias Born | 10/19/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 23, 2009 8:13:34 AM
You forget, we live in a day when all ventures are supposed to turn out OK and on OUR timetable
If not, by GOD, somebody better make restitution!
Even if NNVC were to eventually totally disappear someday, I feel pretty confident it will hit $3/share before then on some sort of news or market hype. That is a 3 banger from here at least.
This I believe is the worst case scenario.
But don't listen to me. I have been investing for 30+ years and loosing all the way. NNVC is what I boiled down to be the most likely best last shot to recoup a portion of the damage incurred from my mistakes. If something worse than my worst case senario occurs, well then, I will just give up and enjoy my final days. Days that might even be shorter without the wonderful promise of those great little Nanoviricides......
I love the fact these have such little if any side effects. Listen more closely to the adds for a sleep aids and such that have side effects of kidney failure, brain seisures, neurotransmitter failures, sudden heart failure, cardiovascular collapse, intense suicide tendencies, loss of all motor skills, tenden discorporation, blindness, deafness, loss of all your SKIN and death from infection, lymphoma, instantaneous blood coagulation, massive bleedout, liver failure, bone cancer, I could go one fore hours.
Merry Christmas to all. I sincerely hope eveyone's year ends on a good note and the rest to come are full of joy and happiness. It is 2010 guys and gals. 2010...........life is way way way way way way way way way way way way way toooooooo short. Enjoy the precise moment, it truly is all you have, soaring stocks or not.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM